Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Altman, Edward I. | - |
dc.contributor.author | Bana, Gaurav | - |
dc.date.accessioned | 2008-05-26T13:49:46Z | - |
dc.date.available | 2008-05-26T13:49:46Z | - |
dc.date.issued | 2002-10 | - |
dc.identifier.uri | http://hdl.handle.net/2451/26494 | - |
dc.description.abstract | The third-quarter 2002 default rate for high yield bonds was 4.95%, based on $37.48 billion of defaults. The quarterly default rate is the highest in history, surpassing the first quarter of 1991 rate of 4.80%. One massive default, WorldCom, accounted for $28.30 billion of defaults (76%). Without WorldCom, the third quarter default rate would have only been 1.2%. The dollar weighted default rate for the first three quarters has already broken the record for a single calendar year reaching 10.98%. And, the latest four-quarters’ default rate of 15.01% has also set a record. Again, WorldCom’s huge default contributed about 4% of this record total. The persistently high default rate through the third quarter has resulted in a near record yield spread of 10.10% -- second only to 1990’s 10.50%. The current yield spread is more than 5% above the historical average. We believe the default rate has peaked in Q3-2002 and depending on the size of the decline, we believe the huge yield spread could reflect an over-sold market. Counting WorldCom ($46.0 billion in liabilities), there were more than $197 billion in liabilities of firms which filed for Chapter 11 protection through the third quarter and 26 firms had liabilities greater than $1 billion. The count was 22 firms through the first-half of the year, so the third-quarter number was "only" four, including WorldCom. There were 39 of such firms in 2001 -- a record year. | en |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | FIN-02-050 | en |
dc.title | Defaults & Returns on High Yield Bonds: Analysis Through September 30, 2002 | en |
dc.type | Working Paper | en |
Appears in Collections: | Finance Working Papers |
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.